Bio-Gene Technology Limited announced the appointment of Mr. Rod Valencia as its new Chief Financial Officer (CFO). The Company has made the appointment following a review identifying the role needed to be full-time to enable the necessary support for ever increasing commercial activities, stakeholder management and investor relations. As a result of this decision to move the CFO position to full time, Rod Valencia replaces Roger McPherson who due to other commitments is unable to move to a full time position.

Rod will commence on 26 April 2023 and Roger will remain with the Company on a consultancy basis until 30 June to ensure an orderly handover. Rod is an Australian Chartered Accountant and London Business School MBA with more than twenty-years of experience working as a senior professional for multinational companies such as Shell, McDonald´s, Ernst & Young and SPC Ardmona (Coca Cola) in South America, Australia, and the Middle East. His career encompasses leading in strategic management, organisational transformations, financial management and information technology, delivering sustainable results, and growing both large and small organizations through delivery of service, excellence, and advice.

Additionally, Rod also manages his private early stage investment company Beltramin Investments and has been intimately involved in a range of ASX companies as an investor over the past 10 years. Pleasingly Rod has been an investor in Bio-Gene for several years.